Louise Orcheston-Findlay

Dr. Louise Orcheston-Findlay

Kids Research Institute, Children's Hospital at Westmead
+1
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in Microelectronic Engineering
Verified
Journal Article
Closed access
LOLouise Orcheston-Findlay
Louise Orcheston-Findlay
AHAzadeh Hashemi
Azadeh Hashemi
AGAshley Garrill
Ashley Garrill
VNVolker Nock
Volker Nock

Verified
Journal Article
Open access
PDF file
LOLouise Orcheston-Findlay
Louise Orcheston-Findlay
SBSamuel Bax
Samuel Bax
RURobert Utama
Robert Utama
MEMartin Engel
Martin Engel
DGDinisha Govender
Dinisha Govender
GOGeraldine O’Neill
Geraldine O’Neill
The life expectancy of patients with high-grade glioma (HGG) has not improved in decades. One of the crucial tools to enable future improvement is advanced models that faithfully recapitulate the tumour microenvironment; they can be used for high-throughput screening that in future may enable accurate personalised drug screens. Currently, advanced models are crucial for identifying and understanding potential new targets, assessing new chemotherapeutic compounds or other treatment modalities. Recently, various methodologies have come into use that have allowed the validation of complex models—namely, spheroids, tumouroids, hydrogel-embedded cultures (matrix-supported) and advanced bioengineered cultures assembled with bioprinting and microfluidics. This review is designed to present the state of advanced models of HGG, whilst focusing as much as is possible on the paediatric form of the disease. The reality remains, however, that paediatric HGG (pHGG) models are years behind those of adult HGG. Our goal is to bring this to light in the hope that pGBM models can be improved upon.

1 November 2017 in AIP Advances
Verified
Journal Article
Open access
PDF file
AHAzadeh Hashemi
Azadeh Hashemi
FDFanny de Decker
Fanny de Decker
LOLouise Orcheston-Findlay
Louise Orcheston-Findlay
MAM. Azam Ali
M. Azam Ali
MAMaan M. Alkaisi
Maan M. Alkaisi
VNVolker Nock
Volker Nock
This work introduces casein microstructures with surface features as a biodegradable biomedical platform technology for enhancing tissue-engineering applications. An optimized fabrication process is presented to reduce the hydrophobicity of intermediate polydimethylsiloxane (PDMS) molds and to transfer high-resolution regular and biomimetic features onto the surface of casein devices. Four different cross-linking reagents, glutaraldehyde, formaldehyde, citric acid and transglutaminase (TG) were investigated to increase the degradation time of casein and their influence on swelling and biocompatibility of the films was studied. TG was found to be the only cross-linker to effectively increase the degradation time and show reduced film swelling after immersion into media, while remaining compatible with cell-culture. The maximum expansion of the films cross-linked via TG was 33% after 24 hours of immersion in cell-culture media. C2C12 cells were successfully cultured on the patterned films for up to 72 hours. The patterned biodegradable casein substrates presented here have promising applications in stem-cell engineering, regenerative medicine, and implantable devices.

1 January 2018 in International Journal of Nanotechnology
Verified
Journal Article
Closed access
LOLouise Orcheston-Findlay
Louise Orcheston-Findlay
AHAzadeh Hashemi
Azadeh Hashemi
VNVolker Nock
Volker Nock
AGAshley Garrill
Ashley Garrill
Inderscience Publishers: publishers of distinguished academic, scientific and professional journals.